2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.
Br. J. Cancer., Jan;67(1):10-4 (1993)
Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.
Gynecol. Oncol., Jan;88(1):35-9 (2003)
Ex vivo programmed cell death and the prediction of response to chemotherapy.
Curr Treat Options Oncol., Mar;7(2):103-10 (2006)
Carboplatin plus gemcitabine repeating doublet therapy in recurrent breast cancer.
Clin. Breast Cancer., Oct;8(5):432-5 (2008)
Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues.
Cancer Chemother. Pharmacol., 26(5):318-22 (1990)
TCL-1, MTCP-1 and TML-1 gene expression profile in non-leukemic clonal proliferations associated with ataxia-telangiectasia.
Int. J. Cancer., Feb;97(6):726-31 (2002)
Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Gynecol. Oncol., Feb;100(2):385-8 (2006)
Gemcitabine plus cisplatin in breast cancer.
Oncology (Williston Park, N.Y.)., Feb;15(2 Suppl 3):28-33 (2001)
Radiation response of cells from human tumor biopsies as assessed by a dye exclusion technique: a possible predictive assay.
Int. J. Radiat. Biol., Nov;56(5):767-70 (1989)